The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 339:918-920 September 24, 1998 Number 13
NextNext

Depression in the Elderly — Falls and Pitfalls

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Thapa, P. B.
-PubMed Citation
Committing a patient to a course of drug therapy, particularly a long-term one, often represents a delicate balancing act in which the physician must juggle estimates of benefit and risk — and increasingly, must factor in costs as well. As with so many things in medicine, the stakes are dramatically higher for the elderly. Older persons have the greatest burden of disease that could benefit from therapeutic or preventive therapy but are also more likely to have side effects from such therapy. These considerations are magnified even further for frail older patients with medically complex conditions who live in nursing . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.